Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06293651
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-05
First Post:
2024-02-15
Brief Title:
Clinical Trial to Investigate Safety Tolerability Pharmacokinetics Pharmacodynamics and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor:
Dong-A ST Co Ltd
Organization:
Dong-A ST Co Ltd
Organization Data
Organization:
Dong-A ST Co Ltd
Class:
INDUSTRY
Study ID:
DA4505_AMST_IIIa
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dong-A ST Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None